Teva Pharma Industries Ltd ADR (TEVA) — Quality & forensics

As of 2026-09-14 — refreshed nightly. Closelook readings from an investment research diary, not ratings or advice.

The Closelook module scores

43 /100 composite · 7 modules · general weight set

Scores are computed nightly across the coverage universe and read relative to it — the methodology lives in the company-scoring explainer.

Financial forensics — the academic screens

0.91 Altman Z-Score

Sits in the distress zone (below 1.81). The Z-Score estimates financial-distress risk from five balance-sheet and earnings ratios.

8/9 Piotroski F-Score

Nine binary fundamental-strength checks across profitability, leverage and operating efficiency.

-2.35 Beneish M-Score

Screens reported earnings for statistical manipulation patterns — below the −1.78 manipulation-risk threshold. A screen, not an accusation.

FAQ · from the current data · as of 2026-09-14

Quick answers

What is Teva Pharma Industries Ltd ADR's Closelook quality reading?

The composite reads 43/100 across 7 modules, as of 2026-09-14: valuation 52, quality 42, growth 48, balance sheet 22, cash quality 38, capital allocation 28, momentum 77. Closelook scores are research diary readings, not ratings or investment advice.

What is Teva Pharma Industries Ltd ADR's Altman Z-Score?

0.91, which sits in the distress zone (below 1.81) as of 2026-09-14. The Altman Z-Score estimates financial distress risk from five balance-sheet and earnings ratios.

What is Teva Pharma Industries Ltd ADR's Piotroski F-Score?

8 of 9, as of 2026-09-14. The F-Score counts nine binary fundamental-strength signals across profitability, leverage and operating efficiency.

What does Teva Pharma Industries Ltd ADR's Beneish M-Score indicate?

-2.35 — below the −1.78 manipulation-risk threshold, as of 2026-09-14. The M-Score screens reported earnings for statistical manipulation patterns; it is a screen, not an accusation.

Related in the Closelook universe